FDA Preparing For Crawford? Lumpkin Named Acting Deputy Commissioner
This article was originally published in The Tan Sheet
Executive Summary
The appointment of former Office of Review Management Director Murray Lumpkin, MD, as acting deputy commissioner makes him the agency's highest ranking physician.
You may also be interested in...
FDA Drug Review Head Is Jenkins, Ending 15-Month Search
Office of Drug Evaluation II Director John Jenkins, MD, will take over as FDA's top drug review manager effective Jan. 2. The agency announced the appointment of Jenkins as Office of Review Management director in a staff memo Dec. 11
FDA Drug Review Head Is Jenkins, Ending 15-Month Search
Office of Drug Evaluation II Director John Jenkins, MD, will take over as FDA's top drug review manager effective Jan. 2. The agency announced the appointment of Jenkins as Office of Review Management director in a staff memo Dec. 11
FDA Drug Review Head Is Jenkins, Ending 15-Month Search
Office of Drug Evaluation II Director John Jenkins, MD, will take over as FDA's top drug review manager effective Jan. 2. The agency announced the appointment of Jenkins as Office of Review Management director in a staff memo Dec. 11